BAX 335 - Asklepios, Takeda
Baxalta: Q4 & FY 2015 Results (Baxalta) - Feb 19, 2016 - Anticipated dosing of last patient in P2 trial (NCT01687608) for hemophilia in 2016 
Anticipated enrollment status • Hemophilia
http://s2.q4cdn.com/643609687/files/doc_presentations/2016/feb/BXLT-Q4-2015-Earnings-Release-Presentation-(FINAL).pdf
 
Feb 19, 2016
 
.
 
76045cd3-3183-451a-99f3-417b5431cb35.jpg